Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.280
+0.080 (6.67%)
At close: Apr 10, 2026, 4:00 PM EDT
1.260
-0.020 (-1.56%)
After-hours: Apr 10, 2026, 7:55 PM EDT
Clearmind Medicine Market Cap
Clearmind Medicine has a market cap or net worth of $2.67 million as of April 10, 2026. Its market cap has decreased by -51.79% in one year.
Market Cap
2.67M
Enterprise Value
-7.67M
1-Year Change
-51.79%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since August 16, 2021, Clearmind Medicine's market cap has decreased from $26.16M to $2.67M, a decrease of -89.78%. That is a compound annual growth rate of -38.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 2.67M | -1.51% |
| Dec 31, 2025 | 2.71M | -55.12% |
| Dec 31, 2024 | 6.05M | 27.14% |
| Dec 29, 2023 | 4.76M | -39.12% |
| Dec 30, 2022 | 7.82M | -59.15% |
| Dec 27, 2021 | 19.13M | -26.88% |
| Aug 16, 2021 | 26.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GRI Bio | 3.47M |
| Matinas BioPharma Holdings | 3.14M |
| GeoVax Labs | 3.10M |
| Decoy Therapeutics | 2.99M |
| Calidi Biotherapeutics | 2.74M |
| Propanc Biopharma | 2.63M |
| Oragenics | 2.60M |
| Adial Pharmaceuticals | 2.36M |